PRESS RELEASE published on 06/16/2023 at 08:00, 3 years 2 months ago DEFENCE MANUFACTURING OF ACCUTOXTM CGMP FINAL DRUG PRODUCT OPTIMIZATION FOR ITS PHASE I CLINICAL TRIAL AT CITY OF HOPE
PRESS RELEASE published on 06/06/2023 at 08:00, 3 years 2 months ago Defence Therapeutics Inc.: DEFENCE BEGINS TESTING ITS ARM VACCINE AGAINST PANCREATIC CANCER
PRESS RELEASE published on 05/24/2023 at 08:00, 3 years 3 months ago Defence Therapeutics Inc.: BREAKTHROUGH RESULTS: DEFENCE’S ARM VACCINE CURED 100% OF ANIMALS WITH PRE-ESTABLISHED LYMPHOMA
PRESS RELEASE published on 05/02/2023 at 08:00, 3 years 3 months ago Defence Therapeutics Inc.: DEFENCE’S SUCCESFULL ACCUTOXTM PRE-CLINICAL EFFICACY STUDY COMPLETE READY FOR PHASE I IND FILING
PRESS RELEASE published on 04/27/2023 at 08:00, 3 years 4 months ago Defence Therapeutics Inc.: USPTO GRANTS TRADEMARK REGISTRATION FOR DEFENCE THERAPEUTICS®
PRESS RELEASE published on 04/24/2023 at 08:00, 3 years 4 months ago Defence Therapeutics Inc.: DEFENCE GRANTED US PATENT WITH BROAD COVERAGE ON ACCUMTM-BASED VACCINE ENHANCER PLATFORM TECHNOLOGY
PRESS RELEASE published on 04/17/2023 at 08:00, 3 years 4 months ago Defence Therapeutics Inc.: DEFENCE'S NOVEL ACCUMTM-mRNA VACCINE NOW ADMINISTERED FOR TESTING ON CANCER
PRESS RELEASE published on 04/11/2023 at 08:00, 3 years 4 months ago DEFENCE BREAKTHROUGH: SUCCESSFULLY ENGINEERED ACCUM(TM) -mRNA VACCINE CREATING A NEW VACCINE PLATFORM. THE IN VIVO ACCUM(TM)-mRNA CANCER VACCINE PROGRAM BEGINS
PRESS RELEASE published on 03/28/2023 at 08:00, 3 years 5 months ago DEFENCE TO COMPLETE A FINAL PRE-CLINICAL STUDY PRIOR TO IND FILINGS FOR THE ACCUTOXTM PHASE I CANCER TRIAL AT THE CITY OF HOPE NATIONAL MEDICAL CENTER AND BECKMAN RESEARCH INSTITUTE
PRESS RELEASE published on 03/14/2023 at 08:00, 3 years 5 months ago DEFENCE THERAPEUTICS SIGNS COLLABORATION AGREEMENT WITH ORANO TO DEVELOP THE NEXT GENERATION OF TARGETED RADIO-IMMUNOTHERAPY FOR CANCER
Published on 08/31/2026 at 17:22, 1 hour 45 minutes ago ACCESS Newswire Expands the Marketplace with Two New Partners: TVEyes and Listicle Liaison
Published on 08/31/2026 at 15:50, 3 hours 17 minutes ago Sarama Resources - Grant of Equity Incentives
Published on 08/31/2026 at 15:00, 4 hours 7 minutes ago Super Copper Featured at OTC Markets' Virtual Investor Conference, Presentation Replay Now Available
Published on 08/31/2026 at 14:30, 4 hours 37 minutes ago While Measles Cases Continue to Increase in The USA and Globally, NanoViricides is Getting Ready for Clinical Trials of Its Revolutionary Broad-spectrum Drug Candidate NV-387 as A Treatment for Measles
Published on 08/31/2026 at 18:20, 47 minutes ago CPI PROPERTY GROUP publishes financial results for the first half of 2026
Published on 08/31/2026 at 18:06, 1 hour ago MELLENU HOLDING S.A. REPORTS RESULTS FOR THE SIX MONTHS ENDING 30 JUNE 2026
Published on 08/31/2026 at 18:04, 1 hour 2 minutes ago PRIMARY HYDROGEN EXPANDS CUMBERLAND BASIN POSITION WITH STAKING OF THE WALLACE PROJECT, NOVA SCOTIA
Published on 08/31/2026 at 17:47, 1 hour 19 minutes ago clearvise AG with successful Annual General Meeting 2026
Published on 08/31/2026 at 16:40, 2 hours 26 minutes ago Grêle : la Vaudoise se mobilise face à plus de 2’000 sinistres attendus
Published on 08/31/2026 at 18:00, 1 hour 7 minutes ago MISE A DISPOSITION RAPPORT FINANCIER ANNUEL 2025/2026
Published on 08/31/2026 at 17:45, 1 hour 22 minutes ago Disclosure of transactions in own shares from August 24 to August 28, 2026
Published on 08/31/2026 at 17:45, 1 hour 22 minutes ago Déclaration hebdomadaire d'opérations effectuées du 24 au 28 août 2026
